Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9172 |
High Similarity |
NPD6232 |
Discontinued |
0.9119 |
High Similarity |
NPD7473 |
Discontinued |
0.8782 |
High Similarity |
NPD1934 |
Approved |
0.8726 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8726 |
High Similarity |
NPD2801 |
Approved |
0.8716 |
High Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8616 |
High Similarity |
NPD3882 |
Suspended |
0.8506 |
High Similarity |
NPD1511 |
Approved |
0.8456 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8397 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8364 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8364 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8364 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8344 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8323 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8322 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8322 |
Intermediate Similarity |
NPD943 |
Approved |
0.8302 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8293 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8272 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8263 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8261 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8261 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8232 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8217 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8217 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8217 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8217 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8182 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD3226 |
Approved |
0.811 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8101 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8065 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8059 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8057 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8038 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8037 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7963 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7953 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7952 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7914 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7892 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7888 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7875 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.787 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7866 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7866 |
Intermediate Similarity |
NPD37 |
Approved |
0.7865 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7848 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7821 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7821 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7816 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7803 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7803 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7792 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7785 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7784 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7759 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7759 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7751 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7738 |
Intermediate Similarity |
NPD919 |
Approved |
0.7725 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7725 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7725 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7725 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7719 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7663 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7632 |
Intermediate Similarity |
NPD9494 |
Approved |
0.763 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7628 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7625 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7602 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7602 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7595 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7595 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7595 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7595 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7595 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7595 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7595 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7586 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7568 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7568 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7568 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7568 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7568 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7568 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7568 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7562 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7544 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7532 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7529 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7516 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7472 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7472 |
Intermediate Similarity |
NPD8313 |
Approved |
0.747 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7457 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7453 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7452 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7447 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7444 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7421 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7401 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7362 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7354 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7354 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7354 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7349 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7349 |
Intermediate Similarity |
NPD920 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7316 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7316 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7303 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7297 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7297 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7292 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7262 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7261 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7256 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7238 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7229 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7216 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7216 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7208 |
Intermediate Similarity |
NPD1283 |
Approved |
0.72 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7191 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7181 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7181 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7167 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7159 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7158 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7091 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7072 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7067 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7063 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7051 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7047 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7047 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7039 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7039 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7025 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7024 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7013 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7005 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7005 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.6995 |
Remote Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6993 |
Remote Similarity |
NPD4626 |
Approved |
0.6989 |
Remote Similarity |
NPD4287 |
Approved |
0.6962 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6954 |
Remote Similarity |
NPD4288 |
Approved |
0.6954
|
Remote Similarity |
NPD5977 |
Approved |